Metabolic and cognitive disorders such as obesity, type 2 diabetes mellitus (T2DM), and Alzheimer’s disease (AD) are associated with insulin resistance within the CNS, which may result from genetic polymorphisms or long-term exposure to elevated levels of circulating insulin due to peripheral insulin resistance. Here, INS is linked to Alzheimer disease.